Cargando…
The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised
CD4(+)CD25(+)FoxP3(+) human regulatory T(CELLS) (T(REG)) are promising candidates for reshaping undesired immunity/inflammation by adoptive cell transfer, yet their application is strongly dependent on robust assays testing their functionality. Several studies along with first clinical data indicate...
Autores principales: | Wendering, Desiree J., Amini, Leila, Schlickeiser, Stephan, Reinke, Petra, Volk, Hans-Dieter, Schmueck-Henneresse, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370705/ https://www.ncbi.nlm.nih.gov/pubmed/30804944 http://dx.doi.org/10.3389/fimmu.2019.00150 |
Ejemplares similares
-
Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients
por: Amini, Leila, et al.
Publicado: (2019) -
Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications
por: Amini, Leila, et al.
Publicado: (2021) -
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients
por: Amini, Leila, et al.
Publicado: (2021) -
Strong Expansion of Human Regulatory T Cells for Adoptive Cell Therapy Results in Epigenetic Changes Which May Impact Their Survival and Function
por: Ou, Kristy, et al.
Publicado: (2021) -
Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
por: Peter, Lena, et al.
Publicado: (2022)